GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol ; volume:25 ; number:1 ; day:2 ; month:9 ; year:2024 ; pages:1-11 ; date:12.2024
Trials ; 25, Heft 1 (2.9.2024), 1-11, 12.2024
- Creator
-
Liu, Qian
Zhou, Huimei
Yu, Mei
Cao, Dongyan
Yang, Jiaxin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-024-08414-0
- URN
-
urn:nbn:de:101:1-2411180055217.333237115475
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Qian
- Zhou, Huimei
- Yu, Mei
- Cao, Dongyan
- Yang, Jiaxin
- SpringerLink (Online service)
Other Objects (12)
Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
Endometrial hyperplasia as a risk factor of endometrial cancer
Endometrial hyperplasia as a risk factor of endometrial cancer
Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases
Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
An altered uterine microbiota with endometrial hyperplasia
Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments
Study of PTEN immunohistochemical expression in endometrial hyperplasia
Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
Increasing utilization of intrauterine device insertion at hysteroscopic endometrial evaluation for patients with endometrial hyperplasia
Assessment of endometrial receptor systems for PPPM approach for endometrial hyperplasia in reproductive age women
Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
Endometrial hyperplasia as a risk factor of endometrial cancer
Endometrial hyperplasia as a risk factor of endometrial cancer
Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases
Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
An altered uterine microbiota with endometrial hyperplasia
Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments
Study of PTEN immunohistochemical expression in endometrial hyperplasia
Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
Increasing utilization of intrauterine device insertion at hysteroscopic endometrial evaluation for patients with endometrial hyperplasia
Assessment of endometrial receptor systems for PPPM approach for endometrial hyperplasia in reproductive age women
Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
Endometrial hyperplasia as a risk factor of endometrial cancer
Endometrial hyperplasia as a risk factor of endometrial cancer
Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases
Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
An altered uterine microbiota with endometrial hyperplasia
Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments
Study of PTEN immunohistochemical expression in endometrial hyperplasia
Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
Increasing utilization of intrauterine device insertion at hysteroscopic endometrial evaluation for patients with endometrial hyperplasia